Pioz MF 15 Tablet SR

Description

About Pioz MF 15 Tablet SR:
Pioz MF 15 Tablet SR combines Pioglitazone, a thiazolidinedione that enhances insulin sensitivity, with Metformin, a biguanide that reduces hepatic glucose production. This combination is prescribed for patients with type 2 diabetes mellitus who require dual mechanism therapy for better glycemic control. The sustained-release (SR) formulation ensures prolonged action and convenient once-daily dosing.

How It Works:

• Pioglitazone: Activates PPAR-gamma receptors, improving insulin sensitivity in muscle, fat, and liver tissues.

• Metformin: Decreases hepatic glucose output and enhances peripheral glucose uptake, lowering blood sugar levels.

• The combination provides complementary effects, addressing both insulin resistance and excess glucose production.

Uses:

• Management of type 2 diabetes mellitus

• Improves insulin sensitivity

• Controls fasting and postprandial blood glucose

• Suitable for patients requiring dual oral antidiabetic therapy

Directions for Use:

• Take once daily, preferably with meals, as prescribed by your doctor.

• Swallow the tablet whole, do not crush or chew.

• Maintain a balanced diet, regular exercise, and healthy lifestyle for optimal blood sugar control.

Side Effects:
Common side effects may include:

• Mild weight gain

• Gastrointestinal discomfort (nausea, diarrhea)

• Edema or fluid retention

• Rare: liver dysfunction or heart failure exacerbation

Seek medical attention if you experience shortness of breath, swelling, sudden weight gain, or signs of liver problems.

Precautions:

• Avoid in patients with heart failure, severe liver or kidney disease, or history of bladder cancer

• Regular monitoring of blood sugar, kidney and liver function, and weight is recommended

• Not recommended during pregnancy or breastfeeding unless prescribed

• Use caution with other antidiabetic drugs to prevent hypoglycemia